FedEx Earnings Rises to $2.13 a Share vs. $1.96 a Share Est.
Immunogen Inc
featured
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
» Read More
More
-
WASHINGTON, Feb 22- U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to other therapies.
-
Feb 22- U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to other therapies.
Most Popular Video
Tuesday, 18 Jun 2013 | 5:58 PM ET
The Fast Money traders share their final trades of the day.
Tuesday, 18 Jun 2013 | 5:00 PM ETAhead of the Fed meeting, the S&P 500 appears headed toward 1,687, StockMonster's Guy Adami says.
Tuesday, 18 Jun 2013 | 6:40 PM ETYou say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.